Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701059 · ClinicalTrials.gov registry record
Comparison of Artificial Disc Implants in Cervical Disc Arthroplasty
A clinical trial of Degenerative Disc Disease and Cervical Radiculopathy, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05701059 is a study of Degenerative Disc Disease and Cervical Radiculopathy that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05701059, a study of Degenerative Disc Disease and Cervical Radiculopathy, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will comprehensively evaluate the outcomes and endpoints of these two different FDA-approved artificial disc implants used to treat cervical spondylotic myelopathy and/or radiculopathy today: Biomet Zimmer Mobi-C and Nuvasive Simplify. Both implants are structurally different with the Nuvasive Simplify implementing a three-piece design with two endplates and a semi-constrained mobile core while the Biomet Zimmer Mobi-C implements an unconstrained three piece design. Subjects will be age-matched and randomly assigned to either implant with informed consent. All subjects will undergo a variety of assessments that evaluate neck disability, quality of life, pain, physiological outcome (radiographic assessments), and neck range-of motion before and after their procedure. One baseline testing will be conducted along with three post-operation visits (three months, six months, and one year) in accordance to standard follow-up procedure. Thus, the duration of participation in the study will be approximately one and a half years.
Conditions Studied
Interventions
- PROCEDURE Cervical arthroplasty
- DEVICE Semi-Constrained Nuvasive Simplify
- DEVICE Unconstrained Biomet Zimmer Mobi-C
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05701059
The ClinicalTrials.gov registry entry for NCT05701059 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (88% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 3 interventions - of which Cervical arthroplasty is the first listed.
NCT05701059 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05701059 about?
NCT05701059 is a clinical study titled "Comparison of Artificial Disc Implants in Cervical Disc Arthroplasty". This study will comprehensively evaluate the outcomes and endpoints of these two different FDA-approved artificial disc implants used to treat cervical spondylotic myelopathy and/or radiculopathy today: Biomet Zimmer Mobi-C and Nuvasive Simplify. Both implants are structurally different with the Nuv...
What is the current status of trial NCT05701059?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-05-01. Estimated completion is 2026-12-01.
What conditions does trial NCT05701059 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Cervical Radiculopathy, Cervical Spondylosis With Myelopathy, Cervical Disc Herniation.
What interventions are being tested in trial NCT05701059?
The interventions under investigation include: Cervical arthroplasty (PROCEDURE), Semi-Constrained Nuvasive Simplify (DEVICE), Unconstrained Biomet Zimmer Mobi-C (DEVICE).
Who is sponsoring clinical trial NCT05701059?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701059 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.